How do SARS-CoV-2 vaccines compare?
Manufacturer/Vaccine | Efficacy based on trials | Dosing | Age Recommendation |
---|---|---|---|
Vaccines currently approved for use | |||
Moderna, mRNA-1273 | 94.5% effective | Two doses 4 weeks apart | 18 years and up |
Pfizer BioNTech | 95% effective | Two doses 3 weeks apart | 16 years and up |
Expected soon | |||
AstraZeneca | 70% | Two doses 3 weeks apart | Not yet available |
Johnson & Johnson | 97% | One dose | 18 – 59 years |
Centers for Disease Control Recommendations
PHASE I distribution: Already begun, projected to go through early summer ‘21
TX Dept of Health COVID-19 vaccine phases vary slightly: 1A Direct care providers, 1A Long-term care residents, 1B Persons 65+ or 16 with at least 1 chronic medical condition, including pregnancy.